Metabolites which (A) persistently increased and (B) persistently decreased with smoking. by Charmion I. Cruickshank-Quinn (595143)

“…PIP = phosphatidylinositol phosphate, PS = phosphatidylserine, TG = triglyceride, DG = diglyceride, PE = phosphatidylethanolamine. Fold change ≥1.5; <i>p</i>-value≤0.05, x-axis = Log2 normalized abundance scale; Error bars represent 95% confidence; Significance values *≤0.05, **≤0.01, ***≤0.001.…”

Complete data. by Jan Víteček (11434774)

“…The rt-PA became increasingly less efficient for clots larger than 50 μl at a clinically relevant concentration of 1.3 mg/l. A tenfold decrease or increase in concentration induced only a 2-fold decrease or increase in clot degradation. …”

Fig 4 - by Jan Víteček (11434774)

“…The rt-PA became increasingly less efficient for clots larger than 50 μl at a clinically relevant concentration of 1.3 mg/l. A tenfold decrease or increase in concentration induced only a 2-fold decrease or increase in clot degradation. …”

The concentrations of VEGFR2 secreted from the vertebral endplate during organ culture (ng/L, n = 4, x ± s). by Jia-Wen Zhan (9028652)

Neudesin: a neuropeptide hormone decreased in subjects with polycystic ovary syndrome by Giray Bozkaya (8739405)

HEWL interacts with dissipated oleic acid micelles, and decreases oleic acid cytotoxicity by Qin Huang (49441)

Decrease of IL-6 and increase of IL-10 secretion in HESN derived-neutrophils after TLR4 stimulation. by Juan C. Hernandez (704571)

RETRACTED ARTICLE: MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt/β-catenin signaling through targeting BC... by Bowen Yao (1835059)

Subjects:

Missense Variant in MAPK Inactivator <i>PTPN5</i> Is Associated with Decreased Severity of Post-Burn Hypertrophic Scarring by Ravi F. Sood (263139)

“…Of 2,146 SNPs tested, a rare missense variant in the <i>PTPN5</i> gene (rs56234898; minor allele frequency 1.5%) was significantly associated with decreased severity of post-burn HTS (<i>P</i> = 1.3×10⁻⁶). …”

GSK343 treatment decreased <i>in vivo</i> tumor volume and growth. by Laura V. Bownes (10276762)

“…Tumor volumes were monitored three times per week. (A) Animals treated with GSK343 had significantly decreased fold change in tumor volumes compared to mice treated with vehicle. …”

Glucagon resistance and decreased susceptibility to diabetes in a model of chronic hyperglucagonemia by Nadejda Bozadjieva Kramer (9657179)

TLR1/6 polymorphisms are associated with decreased lipopeptide-induced IL-6 and IL-10 production in PBMCs. by April Kaur Randhawa (125094)

Image_2_A Shift in Myeloid Cell Phenotype via Down Regulation of Siglec-1 in Island Macrophages of Bone Marrow Is Associated With Decreased Late Erythroblasts Seen in Anemia of Cri... by Shirin Hasan (7894118)

“…There was only a marginal increase in the number of EBIMØ after burn, but, between the signatures of EBIMØ, Siglec-1 expression (MFI) was reduced by 40% in B with and a parallel 44% decrease in TBM erythrons in the BM. There were more (2.5-fold) EEBs and less LEBs (2.4-fold) per million TBM cells in B; with a corresponding decrease in Siglec-1 and Ly6G expressions in EBIMØ associated with EEB. …”

Transduction of Gsx2 decreases the capacity of GESCs to differentiate into neurons, astrocytes and oligodendrocytes. by Héctor R. Méndez-Gómez (189198)

A heat map was generated for all the miRs utilized in the array, as a function of a fold change from referent control values. by Stephanie L. Samani (17896610)

Genes whose expression is decreased in <i>AP2-L</i>(−) parasites. by Shiroh Iwanaga (121019)

“…Genes whose expression was decreased at least three-fold by depletion of <i>AP2-L</i> are listed. …”

GFRα2 expression was dramatically decreased in Runx1 knockout mice. by Ting Wang (16292)

“…GFRα2 and Runx1 decreased concurrently. GFRα1 and GFRα3 increased at 6 d post transection confirming previous rat ISH studies. …”

TGFβ1 decreases p27 phosphorylation at Thr187 in the gastric mucosa of 14-day-old rats during fasting. by Ana P. Z. P. Fiore (593811)

Schematic representation of the molecular mechanism by which iRF decreases the aggressiveness of B16F10 cells. by Daisy Machado (288559)

“…In addition, cell survival mediator, mTOR, was less active as well as Src kinase, an important key player of cell invasion. As we have shown previously in other cancer cell lines, iRF also induced B16F10 cells death by apoptosis since the expression of anti-apoptotic protein Bcl-2 is reduced. …”

Herceptin down-regulates HER2 receptors and decreases HER3 phosphorylation, but it does not decrease HER2 phosphorylation. by Merel Gijsen (234741)